S&P 500 Futures
(-0.07%) 5 143.25 points
Dow Jones Futures
(-0.04%) 38 542 points
Nasdaq Futures
(0.01%) 17 906 points
Oil
(-0.30%) $82.38
Gas
(1.38%) $2.06
Gold
(-1.14%) $2 330.80
Silver
(-2.49%) $26.97
Platinum
(-0.73%) $954.50
USD/EUR
(0.22%) $0.934
USD/NOK
(0.43%) $11.03
USD/GBP
(0.25%) $0.798
USD/RUB
(-0.24%) $93.08

实时更新: Novocure Ltd [NVCR]

交易所: NASDAQ 部门: Healthcare 工业: Medical Instruments & Supplies
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-02)

Expected move: +/- 13.26%

BUY
71.43%
return 6.71%
SELL
71.43%
return -3.76%
最后更新时间30 Apr 2024 @ 04:00

1.31% $ 12.80

出售 108771 min ago

@ $15.54

发出时间: 15 Feb 2024 @ 01:55


回报率: -17.62%


上一信号: Feb 15 - 01:01


上一信号: 购买


回报率: 1.34 %

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 04:00):

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China...

Stats
今日成交量 957 402
平均成交量 1.29M
市值 1.38B
EPS $0 ( 2024-02-22 )
下一个收益日期 ( $-0.420 ) 2024-05-02
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -6.56
ATR14 $0.0100 (0.08%)
Insider Trading
Date Person Action Amount type
2024-03-01 Groenhuysen Wilhelmus Cm Sell 2 107 Ordinary Shares
2024-03-04 Groenhuysen Wilhelmus Cm Sell 1 217 Ordinary Shares
2024-03-01 Leonard Frank X Sell 1 679 Ordinary Shares
2024-03-04 Leonard Frank X Sell 840 Ordinary Shares
2024-02-27 Cordova Ashley Buy 102 249 Ordinary Shares
INSIDER POWER
77.64
Last 92 transactions
Buy: 1 705 026 | Sell: 238 995

音量 相关性

長: -0.29 (neutral)
短: -0.74 (moderate negative)
Signal:(35.119) Neutral

Novocure Ltd 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Novocure Ltd 相关性 - 货币/商品

The country flag 0.48
( neutral )
The country flag 0.36
( neutral )
The country flag 0.00
( neutral )
The country flag 0.46
( neutral )
The country flag 0.03
( neutral )
The country flag -0.54
( weak negative )

Novocure Ltd 财务报表

Annual 2023
营收: $509.34M
毛利润: $381.06M (74.81 %)
EPS: $-1.950
FY 2023
营收: $509.34M
毛利润: $381.06M (74.81 %)
EPS: $-1.950
FY 2022
营收: $537.84M
毛利润: $422.97M (78.64 %)
EPS: $-0.880
FY 2021
营收: $535.03M
毛利润: $420.15M (78.53 %)
EPS: $-0.563

Financial Reports:

No articles found.

Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。